Clinical Impact Through AI-assisted MS Care - A Prospective Multi-center Study

NANot yet recruitingINTERVENTIONAL
Enrollment

750

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

August 31, 2028

Study Completion Date

December 31, 2028

Conditions
Multiple SclerosisRadiologically Isolated SyndromeClinically Isolated Syndrome
Interventions
DEVICE

quantitative brain MRI (icobrain mr)

"Quantitative brain MRI refers to using a specialised software to compute volumes of brain structures and of MS lesions from brain MRI scans, and to measures differences between a previous brain MRI scan and the current brain MRI scan.~The quantitative brain MRI solution being investigated in the PROCLAIM study is icobrain mr, a software solution that uses artificial intelligence (AI) to help with tracking of MS disease progression by measuring brain structures and lesions on magnetic resonance imaging (MRI)."

OTHER

Standard of Care (SOC)

Standard of Care practices at each participating site for management of multiple sclerosis.

Trial Locations (6)

44791

Katholisches Klinikum Bochum - St. Joseph-Hospital, Bochum

131256

Charité - Universitätsmedizin Berlin, Berlin

2 128 00

General University Hospital Prague, Prague

01062

Technische Universität Dresden, Dresden

Unknown

ASST Papa Giovanni XXIII Bergamo, Bergamo

Casa di Cura Igea, Milan

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Ruhr University of Bochum

OTHER

collaborator

Technische Universität Dresden

OTHER

collaborator

Casa di Cura IGEA

OTHER

collaborator

General University Hospital, Prague

OTHER

collaborator

Charite University, Berlin, Germany

OTHER

lead

icometrix

INDUSTRY